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EXPERIMENTAL SECTION

Raw material supplies and instrumental:
Silica gel column chromatography was performed using Sorbent silica gel standard grade, porosity 60Å, particle size 32-63 µm (230 x 450 mesh), surface area 500 -600 m 2 /g, bulk density 0.4 g/mL, pH range 6.5 -7.5, purchased from Sorbent Technologies (Atlanta, GA). All other reagents, purchased from the Aldrich Chemical Company (Milwaukee, WI), were used without further purification. 1 H NMR was taken on a Bruker AV-I console operating at 400.13 MHz. Experimental conditions included 2048 x 512 data matrix, 13 ppm sweep width, recycle delay of 1.5 seconds and 4 scans per increment. The data were processed using squared sinebell window function, symmetrized, and displayed in magnitude mode. Multiplicity-edited HSQC experiments were acquired using a 2048 x 256 data matrix, a J(C-H) value of 145 Hz which resulted in a multiplicity selection delay of 34 ms, a recycle delay of 1.5 seconds and 16 scans per increment along with GARP decoupling on 13 C during the acquisition time (150 ms). The data were processed using a p/2 shifted squared sine window function and displayed with CH/CH 3 signals phased positive and CH 2 signals phased negative. J 1 (C-H) filtered HMBC experiments were acquired using a 2048 x 256 data matrix, a J(C-H) value of 9
Hz for detection of long range couplings resulting in an evolution delay of 55ms, J 1 (C-H) filter delay of 145 Hz (34 ms) for the suppression of one-bond couplings, a recycle delay of 1.5 seconds and 128 scans per increment. The HMBC data were processed using a p/2 shifted squared sine window function and displayed in magnitude mode. Mass spectrometric analyses were performed on a ThermoElectron Surveyor pump TSQ 7000 instrument in ESI positive or negative ion mode. The radiochemical yield was determined by TLC using a radioactivity scanner (Bioscan, Inc., Washington, D.C.).
Synthesis of β β β β-diketones (compounds B):
4,4,4-Trifluoromethyl-1-(4-iodophenyl)butane-1,3-dione, General Procedure:
To a stirred solution of methyltrifluoroacetate (4.23 g, 33 mmol) in methyl t-butyl ether (60 mL) was added 25% NaOMe in MeOH (8.82 mL, 39 mmol) followed by 4-iodoacetophenone (7.38 g, 30 mmol) in methyl t-butyl ether (115 mL). The reaction mixture was stirred for 48 h at room temperature. The reaction was quenched with 3N HCl (14 mL) then ether (100 mL) was added for extraction. The organic layer was separated and washed with water and brine and dried over Na 2 SO 4 . The solvent was removed completely. The crude solid was purified using a silica gel column chromatography 
Methyl 4-(3-iodophenyl)-2,4-dioxobutanoate:
Yellow solid (70 % reaction was poured into 5% HCl (125 mL), then ether (100 mL) was added for extraction. The organic layer was separated and washed with 10% NaOH. The aqueous layer was acidified with 4N HCl, which was extracted with ether (3 X 100 mL). The combined organic layer was dried with Na 2 SO 4 and evaporated to dryness and the product was recrystallized from ether as a yellow solid (11.76 g, 68 % 
6-(4-
Ethyl 5-(4-iodophenyl)-1-(4-sulfonamidophenyl)-1H-pyrazole-3-carboxylate (4):
Yellow solid (80 % 
3-[1-(4-Sulfonamidophenyl)-5-(3-iodophenyl)-1H-pyrazol-3-yl]propanoic acid (5).
A mixture of 6-(3-iodophenyl)-4,6-dioxohexanoic acid (20 mmol), 4-sulfonamidophenylhydrazine hydrochloride (20 mmol), and TEA (20 mmol) in MeOH (150 mL) was stirred at 25 ºC for 16 h. The mixture was then concentrated in vacuo to a residue, which was partitioned between Et 2 O (150 mL) and 5% aq HCl (150 mL). The ether layer was separated, washed with 5% aq HCl (2 X 40 mL), and brine (40 mL 
3-[1-(4-Sulfonamidophenyl)-5-(4-iodophenyl)-1H-pyrazol-3-yl]propanoic acid (6).
Yellow solid (83 %). 
5-(3-Iodophenyl)-1-(4-methylsulfonylphenyl)-3-(trifluoromethyl)-1H-pyrazole (7):
5-(4-Iodophenyl)-1-(4-methylsulfonylphenyl)-3-(trifluoromethyl)-1H-pyrazole (8):
Yellow solid (82 % 
Methyl 5-(3-iodophenyl)-1-(4-methylsulfonylphenyl)-1H-pyrazole-3-carboxylate (9):
Yellow solid (79 % 
Methyl 5-(4-iodophenyl)-1-(4-methylsulfonylphenyl)-1H-pyrazole-3-carboxylate(10):
Yellow solid (77 %). 1 H NMR (400 MHz, DMSO-d 6 ) δ 3.26 (s, 2H, SO 2 CH 3 ), 3.90 (s, 3H, CH 3 ), 7.25 (s, 1H, =CH), 7.60 (d, J = 8.7 Hz, 7.96 (d, J = 8.8 Hz, 2H, 7.97 (d, J = 8.7 Hz, 2H, 8.03 (d, J = 8.8 Hz, 2H, 
1-(4-Methylsulfonylphenyl)-5-(4-tributylstannylphenyl)-3-(trifluoromethyl)-1H-pyrazole (11):
To a stirred solution of tetrakis(triphenylphosphine)palladium(0) (12 mg, 0.01 mmol) in 1,4-dioxane (2 mL) was added hexabutylditin (174 mg, 0.3 mmol) followed by compound 8 (99 mg, 0.2 mmol). The reaction mixture was refluxed for 8 h. After cooling to room temperature, the reaction mixture was filtered and the solvent was removed in vacuo and product was purified using silica gel column chromatography (1 :
1, n-Hexane : EtOAc) to give the title compound (11) as a yellow solid (70% 
